Managing Civilian Casualties Affected by Nerve Agents

Chemical Warfare Agents: Toxicology and Treatment, Second Edition

Volumn , Issue , 2007, Pages 249-260

  Allister Vale, J ^a   Rice, Paul ^b   Marrs, Timothy C ^a,c,d  

^a CITY HOSPITAL   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^c Edentox Associates   (United Kingdom)

^d UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Ageing process and AChE nerve agent complex monodealkylation; Managing nerve agent civilian casualties; Meteorological factors in air delivery; Nerve agent poisoning and management implications; Nerve agent release training

Indexed keywords

EID: 84890142794     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470060032.ch11     Document Type: Chapter

References (48)

1. Berry WK and Davies DR (1970). The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate. Biochem Pharmacol, 19, 927-934.
2. Coleman IW, Patton GE and Bannard RA (1968). Cholinolytics in the treatment of anticholinesterase poisoning. V. The effectiveness of Parpanit with oximes in the treatment of organophosphorus poisoning. Can J Physiol Pharmacol, 46, 109-117.
3. Darvesh S, Hopkins DA and Geula C (2003). Neurobiology of butyrylcholinesterase. Nat Rev Neurosci, 4, 131-138.
4. Davies DR and Green AL (1956). The kinetics of reactivation, by oximes, of cholinesterase inhibited by organophosphorus compounds. Biochem J, 63, 529-535.
5. Gates M and Renshaw BC (1946). Fluorophosphates and other phosphorus-containing compounds. In: Summary Technical Report of Division 9, Volume 1, pp. 131, 155. Washington, DC, USA: Office of Scientific Research and Development.
6. Gordon JJ and Leadbeater L (1977). The prophylactic use of 1-methyl,2-hydroxyiminomethylpyridinium methanesulfonate (P2S) in the treatment of organophosphate poisoning. Toxicol Appl Pharmacol, 40, 109-114.
7. Green DM, Inns RH and Leadbeater L (1983). Unpublished observations, Porton Down, UK.
8. Harris LW, Heyl WC, Stitcher DL et al. (1978). Effects of 1,1'-oxydimethylene bis-(4-tertbutylpyridinium chloride) (SAD-128) and decamethonium on reactivation of soman-and sarin-inhibited cholinesterase by oximes. Biochem Pharmacol, 27, 757-761.
9. Heilbronn E (1963). In vitro reactivation and 'ageing'of tabun-inhibited blood cholinesterases: studies with N-methylpyridinium-2-aldoxime methane sulphonate and N, N'-trimethylene bis (pyridinium-4-aldoxime) dibromide. Biochem Pharmacol, 12, 25-36.
10. Kaplan DE and Marshall A (1996). The Cult at the End of theWorld: The Incredible Story of Aum. London, UK: Hutchison.
11. Kato T and Hamanaka T (1996). Ocular signs and symptoms caused by exposure to sarin gas. Am J Ophthalmol, 121, 209-210.
12. Krummer S, Thiermann H, Worek F et al. (2002). Equipotent cholinesterase reactivation in vitro by the nerve agent antidotes HI 6 dichloride and HI 6 dimethanesulfonate. Arch Toxicol, 76, 589-595.
13. Leblic C, Cox HM and Le Moan L (1984). Etude de la toxicité de l'eserine, VX et le paraoxon, pour établir un modèle mathematique de l'extrapolation à ̂etre humain. Arch Belg Med Soc Hyg Trav Med (Supplement), 226-242.
14. Lotts vK (1960). Zur Toxikologie und pharmakologie organischer Phosphosäurester. Dtsch Gesundheitsw, 15, 2133-2179.
15. Marrs TC (2004). The role of diazepam in the treatment of nerve agent poisoning in a civilian population. Toxicol Rev, 23, 145-157.
16. Masuda N, Takatsu M, Morinari H et al. (1995). Sarin poisoning in Tokyo subway. Lancet, 345, 1446.
17. Matsui Y, Ohbu S and Yamashina A (1996). Hospital deployment in mass sarin poisoning incident of the Tokyo subway system-an experience at St. Luke's International Hospital, Tokyo Jpn Hosp, 15, 67-71.
18. Maynard RL and Beswick FW (1992). Organophosphorus compounds as chemical warfare agents. In Clinical and Experimental Toxicology of Organophosphates and Carbamates (B Ballantyne, TC Marrs, eds), pp. 373-385. Oxford, UK: Butterworth-Heinemann.
19. Morita H, Yanagisawa N, Nakajima T et al. (1995). Sarin poisoning in Matsumoto, Japan. Lancet, 346, 290-293.
20. Murata K, Araki S, Yokoyama K et al. (1997). Asymptomatic sequelae to acute sarin poisoning in the central and autonomic nervous system 6 months after the Tokyo subway attack. J Neurol, 244, 601-606.
21. Nakajima T, Sato S, Morita H et al. (1997). Sarin poisoning of a rescue team in the Matsumoto sarin incident in Japan. Occup Environ Med, 54, 697-701.
22. Nakajima T, Ohta S, Morita H et al. (1998). Epidemiological study of sarin poisoning in Matsumoto City, Japan. J Epidemiol, 8, 33-41.
23. Nakajima T, Ohta S, Fukushima Y et al. (1999). Sequelae of sarin toxicity at one and three years after exposure in Matsumoto, Japan. J Epidemiol, 9, 337-343.
24. Nohara M, Sekijima Y, Nakajima T et al. (1999). Ocular manifestations in the follow-up of victims after sarin poisoning in Matsumoto area. Jpn J Clin Ophthalmol, 53, 659-663.
25. Nozaki H and Aikawa N (1995). Sarin poisoning in Tokyo subway. Lancet, 345, 1446-1447.
26. Nozaki H, Aikawa N, Shinozawa Y et al. (1995). Sarin poisoning in Tokyo subway. Lancet, 345, 980-981.
27. Nozaki H, Hori S, Shinozawa Y et al. (1997). Relationship between pupil size and acetylcholinesterase activity in patients exposed to sarin vapor. Intensive Care Med, 23, 1005-1007.
28. Ohbu S, Yamashina A, Takasu N et al. (1997). Sarin poisoning on Tokyo subway. South Med J, 90, 587-593.
29. Okudera H (2002). Clinical features on nerve gas terrorism in Matsumoto. J Clin Neurosci, 9, 17-21.
30. Okudera H, Morita H, Iwashita T et al. (1997). Unexpected nerve gas exposure in the city of Matsumoto: report of rescue activity in the first sarin gas terrorism. Am J Emerg Med, 15, 527-528.
31. Okumura T, Takasu N, Ishimatsu S et al. (1996). Report on 640 victims of the Tokyo subway sarin attack. Ann Emerg Med, 28, 129-135.
32. Sekijima Y, Morita H and Yanagisawa N (1997). Follow-up of sarin poisoning in Matsumoto. Ann Intern Med, 127, 1042.
33. Sidell FR (1974). Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. J Toxicol Clin Toxicol, 7, 1-17.
34. Sidell FR (1992). Clinical considerations in nerve agent intoxication. In: Chemical Warfare Agents (SM Somani, ed.), pp. 155-194. San Diego, CA, USA: Academic Press.
35. Sidell FR (1997). Nerve agents. In: Textbook of Military Medicine. Part I. Warfare, Weaponry and the Casualty. Medical Aspects of Chemical and Biological Warfare. First Edition (R Zajtchuk and RF Bellamy, eds), pp. 129-179. Washington, DC, USA: Borden Institute, Walter Reed Medical Center.
36. Smithson AE (2004). Ataxia: The Chemical and Biological Terrorism Threat and the US Response, Henry L. Stimson Center Report. Volume 35. Washington, DC, USA: Henry L Stimson Center.
37. Somani SM, Solana RP and Dube SN (1992). Toxicodynamics of nerve agents. In: Chemical Warfare Agents (SM Somani, ed.), pp. 67-123. San Diego, CA, USA: Academic Press.
38. Suzuki T, Morita H, Ono K et al. (1995). Sarin poisoning in Tokyo subway. Lancet, 345, 980.
39. Suzuki J, Kohno T, Tsukagosi M et al. (1997). Eighteen cases exposed to sarin in Matsumoto, Japan. Intern Med, 36, 466-470.
40. Swaminathan R and Widdop B (2001). Biochemical and toxicological investigation related to OP compounds. In: Organophosphates and Health (L Karalleidde, S Feldman, J Henry, and T Marrs, eds), pp. 357-406. London: Imperial College Press.
41. Tsuchihashi H, Katagi M, Nishikawa M et al. (1998). Identification of metabolites of nerve agent VX in serum collected from a victim. J Anal Toxicol, 22, 383-388.
42. Tsuchihashi H, Katagi M, Tatsuno M et al. (2000). Determination of metabolites of nerve agent Oethyl-S-2-diisopropylaminoethyl methylphosphonothioate (VX). In: Natural and Selected Synthetic Toxins: Biological Implications (AT Tut, and W Gaffield, eds), ACS Symposium Series, Volume 745, pp. 369-386. Washington, DC, USA: American Chemical Society.
43. Tu AT (1999). Anatomy of Aum Shrinrikyo's organization and terrorist attacks with chemical and biological weapons. Arch Toxicol Kinet Xenobiot Metab, 7, 45-84.
44. Tu AT (2000). Overview of sarin terrorist attacks in Japan. In: Natural and Selected Synthetic Toxins: Biological Implications (AT Tut and W Graffield, eds), ACS Symposium Series, Volume 745, pp. 304-317. Washington, DC, USA: American Chemical Society.
45. Wehner JM, Smolen A, Smolen TN et al. (1985). Recovery of acetylcholinesterase activity after acute organophosphate treatment of CNS reaggregate cultures. Fundam Appl Toxicol, 5, 1104-1109.
46. Wilson BH, Hooper MJ, Hansen ME et al. (1992). Reactivation of organophosphorus inhibited AChE with oximes. In: Organophosphates-Chemistry, Fate and Effects (JE Chambers and PE Levi, eds), pp. 107-137. San Diego, CA, USA: Academic Press.
47. Yokoyama K, Ogura Y, Kishimoto M et al. (1995). Blood purification for severe sarin poisoning after the Tokyo subway attack. JAMA, 274, 379.
48. Yokoyama K, Yamada A and Mimura N (1996). Clinical profiles of patients with sarin poisoning after the Tokyo subway attack. Am J Med, 100, 586.